You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Raw chart and full-history price indicators begin at the captured split on Sep 28, 2021; bars on opposite sides are not compared.
Bajaj Healthcare Limited reported Q2 FY27 revenue from operations of INR175.9 crores, up 18.9% Y-o-Y, and PAT growth of 26.9%. It received NCLT approval to acquire Genrx Pharmaceuticals Private Limited.
Illustrative technical + ownership context — a signal mix, not investment advice.
Raw-price comparisons begin at the captured split on Sep 28, 2021; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XBOM:BAJAJHCARE | +3.6% | -4.8% | +6.2% | +5.4% | -22.3% |
Share classes and depositary receipts can have different prices and dividends.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-09-11 | 1.50 INR |
| 2025-09-19 | 1.00 INR |
| 2024-09-23 | 1.00 INR |
| 2023-09-22 | 1.00 INR |
| 2022-09-22 | 1.50 INR |
| 2021-09-28 | 1.00 INR |
| 2020-12-01 | 0.875 INR |
No upcoming investor events are listed for this company yet.
